2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer (English)
- New search for: Walsh, D.
- New search for: Davis, M.
- New search for: Ripamonti, C.
- New search for: Bruera, E.
- New search for: Davies, A.
- New search for: Molassiotis, A.
- New search for: Walsh, D.
- New search for: Davis, M.
- New search for: Ripamonti, C.
- New search for: Bruera, E.
- New search for: Davies, A.
- New search for: Molassiotis, A.
In:
SUPPORTIVE CARE IN CANCER
;
25
, 1
;
333-340
;
2017
-
ISSN:
- Article (Journal) / Print
-
Title:2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer
-
Contributors:Walsh, D. ( author ) / Davis, M. ( author ) / Ripamonti, C. ( author ) / Bruera, E. ( author ) / Davies, A. ( author ) / Molassiotis, A. ( author )
-
Published in:SUPPORTIVE CARE IN CANCER ; 25, 1 ; 333-340
-
Publisher:
- New search for: Springer Science + Business Media
-
Publication date:2017-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 25, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Book review: Oxford textbook of oncology, 3rd editionDavies, A. et al. | 2017
- 3
-
Emergency oncology: development, current position and future direction in the USA and UKCooksley, T. / Rice, T. et al. | 2017
- 9
-
Effects of resistance exercise in women with or at risk for breast cancer-related lymphedemaSimonavice, E. / Kim, J. S. / Panton, L. et al. | 2017
- 17
-
A tiered multidisciplinary approach to the psychosocial care of adult cancer patients integrated into routine care: the PROMPT study (a cluster-randomised controlled trial)Turner, J. / Kelly, B. / Clarke, D. / Yates, P. / Aranda, S. / Jolley, D. / Forbes, A. / Chambers, S. / Hargraves, M. / Mackenzie, L. et al. | 2017
- 27
-
Treating an oft-unrecognized and troublesome entity: using gastric electrical stimulation to reduce symptoms of malignancy-associated gastroparesisShah, H. / Wendorf, G. / Ahmed, S. / McElmurray, L. / Lahr, C. / Hughes, M. / Beauerle, B. / Miller, E. / Stocker, A. / Abell, T. L. et al. | 2017
- 33
-
Four-week prehabilitation program is sufficient to modify exercise behaviors and improve preoperative functional walking capacity in patients with colorectal cancerChen, B. P. / Awasthi, R. / Sweet, S. N. / Minnella, E. M. / Bergdahl, A. / Santa Mina, D. / Carli, F. / Scheede-Bergdahl, C. et al. | 2017
- 41
-
Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational studyMatsuo, N. / Morita, T. / Matsuda, Y. / Okamoto, K. / Matsumoto, Y. / Kaneishi, K. / Odagiri, T. / Sakurai, H. / Katayama, H. / Mori, I. et al. | 2017
- 51
-
Adapting an Australian question prompt list in oncology to a Norwegian setting—a combined method approachAmundsen, A. / Ervik, B. / Butow, P. / Tattersall, M. H. / Bergvik, S. / Sørlie, T. / Nordøy, T. et al. | 2017
- 59
-
Venous thromboembolism treatment outcomes in cancer patients and effect of third-party payers on anticoagulant choiceJean, G. W. / Kelly, K. / Mathew, J. / Larumbe, E. / Hughes, R. et al. | 2017
- 67
-
Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial designRussell, N. S. / Werkhoven, E. / Schagen, S. B. et al. | 2017
- 75
-
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysisFarias, A. J. / Ornelas, I. J. / Hohl, S. D. / Zeliadt, S. B. / Hansen, R. N. / Li, C. I. / Thompson, B. et al. | 2017
- 85
-
Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapyChasen, M. / Urban, L. / Schnadig, I. / Rapoport, B. / Powers, D. / Arora, S. / Navari, R. / Schwartzberg, L. / Gridelli, C. et al. | 2017
- 93
-
Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up studyBeesley, V. L. / Smithers, B. M. / O’Rourke, P. / Janda, M. / Khosrotehrani, K. / Green, A. l. et al. | 2017
- 103
-
Feasibility of implementing the ‘Screening for Distress and Referral Need’ process in 23 Dutch hospitalsNuenen, F. M. / Donofrio, S. M. / Tuinman, M. A. / Wiel, H. B. / Hoekstra-Weebers, J. E. et al. | 2017
- 111
-
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR)Bongiovanni, A. / Monti, M. / Foca, F. / Recine, F. / Riva, N. / Di Iorio, V. / Liverani, C. / De Vita, A. / Miserocchi, G. / Mercatali, L. et al. | 2017
- 119
-
What do adolescents and young adults want from cancer resources? Insights from a Delphi panel of AYA patientsCheung, C. K. / Zebrack, B. et al. | 2017
- 127
-
A guided self-help intervention targeting psychological distress among head and neck cancer and lung cancer patients: motivation to start, experiences and perceived outcomesKrebber, A. M. / Uden-Kraan, C. F. / Melissant, H. C. / Cuijpers, P. / Straten, A. / Becker-Commissaris, A. / Leemans, C. R. / Verdonck-de Leeuw, I. M. et al. | 2017
- 137
-
Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW AustraliaSmith, J. / Poon, C. / Gilroy, N. / Kabir, M. / Brice, L. / Dyer, G. / Hogg, M. / Greenwood, M. / Moore, J. / Hertzberg, M. et al. | 2017
- 145
-
Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled studyMukhopadhyay, S. / Kwatra, G. / Alice K, P. / Badyal, D. et al. | 2017
- 155
-
Erratum to: Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled studyMukhopadhyay, S. / Kwatra, G. / K, P. A. / Badyal, D. et al. | 2017
- 157
-
Experiences of incontinence and pelvic floor muscle training after gynaecologic cancer treatmentLindgren, A. / Dunberger, G. / Enblom, A. et al. | 2017
- 167
-
Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancerStarkweather, A. / Kelly, D. L. / Thacker, L. / Wright, M. L. / Jackson-Cook, C. K. / Lyon, D. E. et al. | 2017
- 177
-
Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in JordanShamieh, O. / Khamash, O. / Khraisat, M. / Jbouri, O. / Awni, M. / Al-Hawamdeh, A. / Arja, G. / Ajarmeh, S. / Al-Rimawi, D. / Hui, D. et al. | 2017
- 185
-
The influence of dyadic symptom distress on threat appraisals and self-efficacy in advanced cancer and caregivingEllis, K. R. / Janevic, M. R. / Kershaw, T. / Caldwell, C. H. / Janz, N. K. / Northouse, L. et al. | 2017
- 195
-
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)Schloss, J. M. / Colosimo, M. / Airey, C. / Masci, P. / Linnane, A. W. / Vitetta, L. et al. | 2017
- 205
-
Infusion reactions are common after high-dose carmustine in BEAM chemotherapy and are not reduced by lengthening the time of administrationPerreault, S. / Baker, J. / Medoff, E. / Pratt, K. / Foss, F. / Isufi, I. / Seropian, S. / Cooper, D. L. et al. | 2017
- 209
-
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of careAntonuzzo, A. / Vasile, E. / Sbrana, A. / Lucchesi, M. / Galli, L. / Brunetti, I. M. / Musettini, G. / Farnesi, A. / Biasco, E. / Virgili, N. et al. | 2017
- 213
-
Patient- and family-centered care: a qualitative exploration of oncologist perspectivesNguyen, T. K. / Bauman, G. S. / Watling, C. J. / Hahn, K. et al. | 2017
- 221
-
Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncologyMorgan, J. E. / Hassan, H. / Cockle, J. V. / Lethaby, C. / James, B. / Phillips, R. S. et al. | 2017
- 229
-
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patientsAlkan, A. / Yaşar, A. / Karcı, E. / Köksoy, E. B. / Ürün, M. / Şenler, F. a. / Ürün, Y. k. / Tuncay, G. l. / Ergün, H. / Akbulut, H. et al. | 2017
- 237
-
Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefitsFallowfield, L. J. / Catt, S. L. / May, S. F. / Matthews, L. / Shilling, V. M. / Simcock, R. / Westwell, S. / Jenkins, V. A. et al. | 2017
- 245
-
The multidimensional burden of informal caregivers in primary malignant brain tumorBayen, E. o. / Laigle-Donadey, F. / Prouté, M. / Hoang-Xuan, K. / Joël, M. E. / Delattre, J. Y. et al. | 2017
- 255
-
Psychological distress of cancer patients with children under 18 years and their partners—a longitudinal study of family relationships using dyadic data analysisGötze, H. / Friedrich, M. / Brähler, E. / Romer, G. / Mehnert, A. / Ernst, J. et al. | 2017
- 265
-
Special Section: MASCC/ESMO Antiemetic Guidelines| 2017
- 267
-
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline updateMolassiotis, A. / Aapro, M. / Herrstedt, J. / Gralla, R. / Roila, F. et al. | 2017
- 271
-
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agentsJordan, K. / Chan, A. / Gralla, R. J. / Jahn, F. / Rapoport, B. / Warr, D. / Hesketh, P. J. et al. | 2017
- 277
-
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyHerrstedt, J. r. / Roila, F. / Warr, D. / Celio, L. / Navari, R. M. / Hesketh, P. J. / Chan, A. / Aapro, M. S. et al. | 2017
- 289
-
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyRoila, F. / Warr, D. / Hesketh, P. J. / Gralla, R. / Herrstedt, J. / Jordan, K. / Aapro, M. / Ballatori, E. / Rapoport, B. et al. | 2017
- 295
-
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyRoila, F. / Warr, D. / Hesketh, P. J. / Gralla, R. / Herrstedt, J. / Jordan, K. / Aapro, M. / Ballatori, E. / Rapoport, B. et al. | 2017
- 297
-
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialOlver, I. / Ruhlmann, C. H. / Jahn, F. / Schwartzberg, L. / Rapoport, B. / Rittenberg, C. N. / Clark-Snow, R. et al. | 2017
- 303
-
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomitingEinhorn, L. H. / Rapoport, B. / Navari, R. M. / Herrstedt, J. r. / Brames, M. J. et al. | 2017
- 309
-
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomitingRuhlmann, C. H. / Jahn, F. / Jordan, K. / Dennis, K. / Maranzano, E. / Molassiotis, A. / Roila, F. / Feyer, P. et al. | 2017
- 317
-
2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapyDupuis, L. L. / Roscoe, J. A. / Olver, I. / Aapro, M. / Molassiotis, A. et al. | 2017
- 323
-
2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in childrenDupuis, L. L. / Sung, L. / Molassiotis, A. / Orsey, A. D. / Tissing, W. / Wetering, M. et al. | 2017
- 333
-
2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancerWalsh, D. / Davis, M. / Ripamonti, C. / Bruera, E. / Davies, A. / Molassiotis, A. et al. | 2017